| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| ADRA2A |
HGNC:281 |
P08913 |
5-[2-(4-naphthalen-1-ylpiperazin-1-yl)ethyl]-2,3-dihydro-1H-benzimidazole |
10546334 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperidin-4-ylmethyl]-amine |
10548781 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(3,4-Dimethoxy-2-methyl-phenyl)-(1H-imidazol-2-yl)-amine |
10609673 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-(1-phenyl-piperidin-4-ylmethyl)-amine |
10664759 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(5-Methoxy-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-(1-pyrimidin-2-yl-piperidin-4-ylmethyl)-amine |
10666853 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1-(4-methoxy-phenyl)-piperidin-4-ylmethyl]-amine |
10690393 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1-(2,3-dihydro-benzofuran-7-yl)-piperidin-4-ylmethyl]-amine |
10691211 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
[1-(2-Chloro-phenyl)-piperidin-4-ylmethyl]-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-amine |
10714368 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(2,3-Dihydro-indol-1-yl)-{3-[4-(2-isopropoxy-phenyl)-piperazin-1-ylmethyl]-phenyl}-methanone |
10718592 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-N'-pyrimidin-2-ylethane-1,2-diamine |
10731942 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(2-Methyl-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-(1-pyrimidin-2-yl-piperidin-4-ylmethyl)-amine |
10736855 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(8-Methoxy-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-(1-pyrimidin-2-yl-piperidin-4-ylmethyl)-amine |
10737897 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-[[(3R)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-1-[1-(2-methoxyphenyl)piperidin-4-yl]methanamine |
10761543 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-1-(1-pyrimidin-2-ylpiperidin-4-yl)methanamine |
10783359 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(S)-(-)-N-(1,4-benzodioxan-2-ylmethyl)-1-[1-(2-methoxyphenyl)-piperid-4-yl]methylamine |
10785265 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
[1-(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperidin-4-ylmethyl]-(2-methoxy-phenyl)-amine |
10785266 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-[[(3R)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-1-(1-pyrimidin-2-ylpiperidin-4-yl)methanamine |
10807090 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1-(3-methoxy-phenyl)-piperidin-4-ylmethyl]-amine |
10832838 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)H-pyrazolo[1,5-a]pyridine-6-carboxamide |
10862425 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)H-pyrazolo[1,5-a]pyridine-3-carboxamide |
10884046 |
TTD |